Regulatory T cells and breast cancer: implications for immunopathogenesis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://link.springer.com/content/pdf/10.1007/s10555-010-9247-y.pdf
Reference100 articles.
1. Chu, D., & Lu, J. (2008). Novel therapies in breast cancer: What is new from ASCO 2008. Journal of Hematology Oncology, 1, 1–16.
2. Kásler, M., Polgár, C., & Fodor, J. (2009). Current status of treatment for early-stage invasive breast cancer. Orvosi Hetilap, 150, 1013–1021.
3. Benz, C. C. (2008). Impact of aging on the biology of breast cancer. Impact of aging on the biology of breast cancer. Critical Reviews in Oncology/Hematology, 66(1), 65–74.
4. Lacroix, M., Toillon, R. A., & Leclercq, G. (2004). Stable ‘portrait’ of breast tumors during progression: Data from biology, pathology and genetics. Endocrine-Related Cancer, 11, 497–522.
5. Rakha, E. A., El-Sayed, M. E., Reis-Filho, J., & Ellis, I. O. (2009). Patho-biological aspects of basal-like breast cancer. Breast Cancer Research and Treatment, 113, 411–422.
Cited by 105 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Potential tools for predicting response to chemotherapy in OC: Assessment of immune dysbiosis, participant’s self-rated health and microbial dynamics;Journal of Reproductive Immunology;2024-06
2. The Virtual Screening of Compounds from the ZINC Database against PARP‐1 in Triple‐Negative Breast Cancer;ChemistrySelect;2024-03-08
3. Targeting the breast tumor microenvironment by plant-derived products and their nanoformulations;Journal of Drug Delivery Science and Technology;2024-03
4. Anti‐cathepsin D immunotherapy triggers both innate and adaptive anti‐tumour immunity in breast cancer;British Journal of Pharmacology;2024-01-26
5. Apigenin promotes apoptosis of 4T1 cells through PI3K/AKT/Nrf2 pathway and improves tumor immune microenvironment in vivo;Toxicology Research;2024-01-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3